Pfizer announced its performance on July 30th, with Q2 2024 revenue of $13.3 billion. Pfizer expects its annual revenue to be between $59.5 billion and $62.5 billion, with an estimated adjusted earnings per share of $2.45 to $2.65 for the full year.